Cardiovascular death and first heart failure hospitalization was reduced among HFrEF patients compared to HFmrEF and HFpEF ...
Grade 3-5 adverse events were comparable between both treatment groups. Evidence Rating Level: 1 (Excellent) Study Rundown: ...
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
In a randomized triple-blinded controlled trial, probiotic and vitamin D supplementation did not significantly change ...
In this cross-sectional study, researchers found that Native Hawaiian and Pacific Islander (NHPI) adults aged 35 years or ...
In this randomized controlled trial, among adolescent girls and young women, it was found that twice-yearly lenacapavir ...
Zodasiran, an RNA interference (RNAi) therapy targeting angiopoietin-like 3 (ANGPTL3), resulted in a dose-dependent reduction ...
Predicting dementia in primary care settings for a 60-79 year old cohort should include age, history of stroke or epilepsy, gait problems, anticholinergic burden, use of SSRIs, receipt of social ...